Department of Chemistry, Graduate School, Kyung Hee University, Yongin-si, Gyeonggi-do, 17104, Republic of Korea.
Department of Physiology, Ajou University School of Medicine, 164, World cup-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do, 16499, Republic of Korea.
J Nanobiotechnology. 2021 Nov 29;19(1):398. doi: 10.1186/s12951-021-01147-1.
Nanoparticles have been used for biomedical applications, including drug delivery, diagnosis, and imaging based on their unique properties derived from small size and large surface-to-volume ratio. However, concerns regarding unexpected toxicity due to the localization of nanoparticles in the cells are growing. Herein, we quantified the number of cell-internalized nanoparticles and monitored their cellular localization, which are critical factors for biomedical applications of nanoparticles.
This study investigates the intracellular trafficking of silica-coated magnetic nanoparticles containing rhodamine B isothiocyanate dye [MNPs@SiO(RITC)] in various live single cells, such as HEK293, NIH3T3, and RAW 264.7 cells, using site-specific direct stochastic optical reconstruction microscopy (dSTORM). The time-dependent subdiffraction-limit spatial resolution of the dSTORM method allowed intracellular site-specific quantification and tracking of MNPs@SiO(RITC).
The MNPs@SiO(RITC) were observed to be highly internalized in RAW 264.7 cells, compared to the HEK293 and NIH3T3 cells undergoing single-particle analysis. In addition, MNPs@SiO(RITC) were internalized within the nuclei of RAW 264.7 and HEK293 cells but were not detected in the nuclei of NIH3T3 cells. Moreover, because of the treatment of the MNPs@SiO(RITC), more micronuclei were detected in RAW 264.7 cells than in other cells.
The sensitive and quantitative evaluations of MNPs@SiO(RITC) at specific sites in three different cells using a combination of dSTORM, transcriptomics, and molecular biology were performed. These findings highlight the quantitative differences in the uptake efficiency of MNPs@SiO(RITC) and ultra-sensitivity, varying according to the cell types as ascertained by subdiffraction-limit super-resolution microscopy.
由于纳米粒子具有小尺寸和大表面积与体积比等独特性质,已被用于生物医药应用,包括药物输送、诊断和成像。然而,由于纳米粒子在细胞内的定位而引起的意外毒性问题也引起了人们的关注。在此,我们量化了细胞内内化的纳米粒子数量,并监测了它们的细胞定位,这是纳米粒子在生物医药应用中的关键因素。
本研究使用位点特异性直接随机光学重建显微镜(dSTORM)研究了含有罗丹明 B 异硫氰酸酯染料[MNPs@SiO(RITC)]的硅涂层磁性纳米粒子在各种活的单细胞中的细胞内转运,如 HEK293、NIH3T3 和 RAW 264.7 细胞。dSTORM 方法的时间依赖性亚衍射极限空间分辨率允许对 MNPs@SiO(RITC)进行细胞内位点特异性定量和跟踪。
与进行单粒子分析的 HEK293 和 NIH3T3 细胞相比,MNPs@SiO(RITC)在 RAW 264.7 细胞中被高度内化。此外,MNPs@SiO(RITC)被内化到 RAW 264.7 和 HEK293 细胞的核内,但在 NIH3T3 细胞的核内未检测到。此外,由于 MNPs@SiO(RITC)的处理,在 RAW 264.7 细胞中检测到更多的微核。
使用 dSTORM、转录组学和分子生物学相结合的方法,对三种不同细胞中 MNPs@SiO(RITC)在特定部位的敏感和定量评价。这些发现强调了 MNPs@SiO(RITC)的摄取效率和超灵敏性的定量差异,根据亚衍射极限超分辨率显微镜确定的细胞类型而有所不同。